Cargando…

The positive clinical therapeutically effects of Escin on advanced thyroid cancer

The incidences of thyroid cancer keep rising worldwide over the past few decades. Although most thyroid cancers are indolent and highly curable, the treatment for advanced thyroid cancer remains challengeable in clinical practice. We performed two separate cohorts to evaluate the safety and efficien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Jin‐Yu, Zhang, Ming‐Jun, Wang, Yuan‐Yuan, Liu, Ye‐Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430090/ https://www.ncbi.nlm.nih.gov/pubmed/28378396 http://dx.doi.org/10.1002/cam4.1031

Ejemplares similares

Molecular Mechanism for Cellular Response to β-Escin and Its Therapeutic Implications
por: Domanski, Dominik, et al.
Publicado: (2016)

Escin’s Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review
por: Fazliev, Sunnatullo, et al.
Publicado: (2023)

Endothelia-Targeting Protection by Escin in Decompression Sickness Rats
por: Zhang, Kun, et al.
Publicado: (2017)

Development and validation of an individualized diagnostic signature in thyroid cancer
por: Han, Li‐ou, et al.
Publicado: (2018)

The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial
por: Zhao, Qun, et al.
Publicado: (2020)

Horse Chestnut Saponins–Escins, Isoescins, Transescins, and Desacylescins
por: Savarino, Philippe, et al.
Publicado: (2023)

β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features
por: Park, Soeun, et al.
Publicado: (2022)

Clinical presentation and survival outcomes of well‐differentiated thyroid cancer in Filipinos
por: Megwalu, Uchechukwu C., et al.
Publicado: (2021)

A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations
por: Li, Hong‐Shuai, et al.
Publicado: (2022)

Effects of marital status on survival of medullary thyroid cancer stratified by age
por: Ai, Lei, et al.
Publicado: (2021)

β-Escin Effectively Modulates HUVECs Proliferation and Tube Formation
por: Varinská, Lenka, et al.
Publicado: (2018)

Rational application of targeted therapeutics in mucinous colon/appendix cancers with positive predictive factors
por: Dilly, Ashokkumar, et al.
Publicado: (2020)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound‐guided radiofrequency ablation for papillary thyroid microcarcinoma
por: Zhang, Yan, et al.
Publicado: (2019)

Progress in the clinical detection of heterogeneity in breast cancer
por: Song, Jun‐Long, et al.
Publicado: (2016)

Oral Administration of Escin Inhibits Acute Inflammation and Reduces Intestinal Mucosal Injury in Animal Models
por: Li, Minmin, et al.
Publicado: (2015)

Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β‐catenin signaling and sensitizes cancer cells to FH535 therapy
por: Wen, Duo, et al.
Publicado: (2018)

Preparation, Purification and Regioselective Functionalization of Protoescigenin—The Main Aglycone of Escin Complex
por: Gruza, Mariusz M., et al.
Publicado: (2013)

Benefits of Escin for Decompression Sickness in Bama Pigs by Endothelial-Targeting Protection
por: Qing, Long, et al.
Publicado: (2019)

Glucocorticoid-Like Activity of Escin: A New Mechanism for an Old Drug
por: Gallelli, Luca, et al.
Publicado: (2021)

Machine learning for the prediction of bone metastasis in patients with newly diagnosed thyroid cancer
por: Liu, Wen‐Cai, et al.
Publicado: (2021)

Prevalence of cancer and the benign call rate of afirma gene classifier in (18)F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules
por: Endo, Mayumi, et al.
Publicado: (2021)

Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancer
por: Obeng‐Gyasi, Samilia, et al.
Publicado: (2020)

Positioning of second‐line treatment for advanced gastric and gastroesophageal junction adenocarcinoma
por: Pericay, Carles, et al.
Publicado: (2016)

Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer
por: Yang, Yuan‐Zhong, et al.
Publicado: (2021)

Antiviral escin derivatives from the seeds of Aesculus turbinata Blume (Japanese horse chestnut)
por: Kim, Ji Won, et al.
Publicado: (2017)

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers
por: Weymann, Deirdre, et al.
Publicado: (2021)

The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma
por: Hu, Jia‐Qian, et al.
Publicado: (2019)

Inhibitory effect of β-escin on Zika virus infection through the interruption of viral binding, replication, and stability
por: Lai, Zheng-Zong, et al.
Publicado: (2023)

Parity and thyroid cancer risk: a meta‐analysis of epidemiological studies
por: Zhu, Jingjing, et al.
Publicado: (2015)

Population‐based study evaluating and predicting the probability of death resulting from thyroid cancer among patients with papillary thyroid microcarcinoma
por: Wang, Kun, et al.
Publicado: (2019)

Corrigendum: Benefits of Escin for Decompression Sickness in Bama Pigs by Endothelial-Targeting Protection
por: Qing, Long, et al.
Publicado: (2019)

Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
por: Gallelli, Luca
Publicado: (2019)

Structure and Undulations of Escin Adsorption Layer at Water Surface Studied by Molecular Dynamics
por: Tsibranska, Sonya, et al.
Publicado: (2021)

The changing face of thyroid cancer in a population-based cohort
por: Alok Pathak, K, et al.
Publicado: (2013)

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
por: Panebianco, Federica, et al.
Publicado: (2019)

BRAF(V600E) mutation test on fine‐needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients
por: Chen, Huang, et al.
Publicado: (2021)

Optimal duration of prior endocrine therapy predicts the efficacy of Fulvestrant in a real‐world study for patients with hormone receptor‐positive and HER2‐negative advanced breast cancer
por: Zhao, Yannan, et al.
Publicado: (2020)

Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?
por: Zhuang, Wei, et al.
Publicado: (2018)

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
por: Honma, Yoshitaka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k5fl48hraktr5t1gvdr3sblqfu